Enlivex Therapeutics has completed a major financing round. The company has raised 212 million through a private placement. The offering was priced at one dollar per share. The price carried an 11.5 per cent premium on the firms last traded value. The raise included US dollars and USDT. Investors viewed the premium as a strong signal of strategic intent.
The company wants to build a new treasury model. Most of the funds will go towards Rain token purchases. The deal is set to close on 25 November. Enlivex believes this new structure will place it in a growing blockchain segment. It has not made a move of this scale before. This also follows an earlier decision to add a small amount of bitcoin to its cash-management plan. The firm did not disclose how much bitcoin it still holds.
Why Enlivex Is Turning to Prediction MarketsRain is the native token of a decentralised prediction markets protocol built on Arbitrum. The system lets users create simple markets. Users then trade positions on outcomes. Smart contracts control every step. Outcomes are settled through oracles or automated tools. It works in a similar way to Polymarket. The platform also includes a buyback and burn model that reduces token supply.
